Showing results (11-20 of 202) with videos related to
Sort By:
Pageof 21
Expert Opinion on Biological Therapy|August 2, 2007
Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitusMassimo Trucco, Nick GiannoukakisAmerican Journal of Therapeutics|November 11, 2005
Gene therapy for type 1 diabetesNick Giannoukakis, Massimo TruccoPlos One|January 28, 2014
Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD miceValentina Di Caro, Brett Phillips, Carl Engman, et al.Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and preventionNick Giannoukakis, Massimo Pietropaolo, Massimo TruccoAdvanced Drug Delivery Reviews|December 7, 2007
Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetesLorenzo Pasquali, Nick Giannoukakis, Massimo TruccoClinical Immunology (Orlando, Fla.)|March 31, 2015
A brief glimpse over the horizon for type 1 diabetes nanotherapeuticsYesica Garciafigueroa, Massimo Trucco, Nick GiannoukakisImmunologic Research|April 9, 2011
Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacityValentina Di Caro, Antonella D'Anneo, Brett Phillips, et al.The Review of Diabetic Studies : RDS|June 28, 2013
In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetesValentina Di Caro, Nick Giannoukakis, Massimo TruccoPediatric Endocrinology Reviews : PER|June 17, 2008
Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitusBrett E Phillips, Nick Giannoukakis, Massimo TruccoFrontiers in Immunology|October 28, 2017
Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune DiseaseBrett Eugene Phillips, Yesica Garciafigueroa, Massimo Trucco, et al.Pageof 21